Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

EMPLOYEES

Share

Genagon Therapeutics AB

Closing information (x1000 NOK)

Closing information 2022/12 2021/12 2020/12
Turnover 70 Less Arrow 34 Less Arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 1
Earnings before taxes -9,295 More Arrow -8,526 More Arrow -5,466
EBITDA -9,290 More Arrow -8,522 More Arrow -5,459
Total assets 5,374 More Arrow 11,350 Less Arrow 2,594
Current assets 5,352 More Arrow 11,321 Less Arrow 2,594
Current liabilities 646 More Arrow 979 Less Arrow 678
Equity capital 4,728 More Arrow 10,371 Less Arrow -2,683
- share capital 193 Less Arrow 183 Less Arrow 130
Employees (average) 3 Equal arrow 3 More Arrow 4

Financial ratios

Fiscal year 2022/12 2021/12 2020/12
Solvency 88.0% More Arrow 91.4% Less Arrow -103.4%
Turnover per employee 23 Less Arrow 11 Less Arrow 0
Profit as a percentage of turnover -13278.6% Less Arrow -25076.5%
Return on assets (ROA) -173.0% More Arrow -75.1% Less Arrow -210.7%
Current ratio 828.5% More Arrow 1156.4% Less Arrow 382.6%
Return on equity (ROE) -196.6% More Arrow -82.2% More Arrow 203.7%
Change turnover 37 Less Arrow 34 Less Arrow 0
Change turnover % 111%
Chg. No. of employees 0 Less Arrow -1 Equal arrow -1
Chg. No. of employees % 0% Less Arrow -25% More Arrow -20%

Total value of public sale

Fiscal year 2022/12 2021/12 2020/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.